<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34468688</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2168-6084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>157</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA dermatology</Title>
          <ISOAbbreviation>JAMA Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prevalence and Characterization of Itch in Pachyonychia Congenita.</ArticleTitle>
        <Pagination>
          <StartPage>1378</StartPage>
          <EndPage>1380</EndPage>
          <MedlinePgn>1378-1380</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamadermatol.2021.3335</ELocationID>
        <Abstract>
          <AbstractText>This survey study examines the prevalence and characteristics of itch in pachyonychia congenita.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Steele</LastName>
            <ForeName>Lloyd</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, The Royal London Hospital, Barts Health National Health Service Trust and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, England.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schwartz</LastName>
            <ForeName>Janice</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>C David</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, Utah.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Utah, Salt Lake City.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Toole</LastName>
            <ForeName>Edel A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, The Royal London Hospital, Barts Health National Health Service Trust and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, England.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JAMA Dermatol</MedlineTA>
        <NlmUniqueID>101589530</NlmUniqueID>
        <ISSNLinking>2168-6068</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="Y">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011537" MajorTopicYN="N">Pruritus</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Conflict of Interest Disclosures:</b> Prof O'Toole reported consulting fees from Palvella Therapeutics, research funding from Kamari Pharma, being a reviewer for LEO Foundation awards and Sanofi, and receiving a Biotechnology and Biological Sciences Research Council cofunded studentship with Unilever outside of the submitted manuscript. No other disclosures were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>12</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34468688</ArticleId>
        <ArticleId IdType="pmc">PMC8411358</ArticleId>
        <ArticleId IdType="doi">10.1001/jamadermatol.2021.3335</ArticleId>
        <ArticleId IdType="pii">2783860</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Samuelov L, Smith FJD, Hansen CD, et al. . Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol. 2020;182(3):738-746. doi:10.1016/j.jid.2019.07.091</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jid.2019.07.091</ArticleId>
            <ArticleId IdType="pubmed">31823354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moons P. Leuven Itch Scale 2.0 Manual. Accessed July 13, 2021. https://gbiomed.kuleuven.be/english/research/50000687/50000693/itchscale</Citation>
        </Reference>
        <Reference>
          <Citation>Pan B, Byrnes K, Schwartz M, et al. . Peripheral neuropathic changes in pachyonychia congenita. Pain. 2016;157(12):2843-2853. doi:10.1097/j.pain.0000000000000711</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000000711</ArticleId>
            <ArticleId IdType="pubmed">27776012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhoff M, Oaklander AL, Szabó IL, Ständer S, Schmelz M. Neuropathic itch. Pain. 2019;160(suppl 1):S11-S16. doi:10.1097/j.pain.0000000000001551</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000001551</ArticleId>
            <ArticleId IdType="pubmed">31008844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson SR, Thé L, Batia LM, et al. . The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285-295. doi:10.1016/j.cell.2013.08.057</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.08.057</ArticleId>
            <ArticleId IdType="pmc">PMC4041105</ArticleId>
            <ArticleId IdType="pubmed">24094650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheffschick A, Kiritsi D, Magin TM. Keratin defects trigger the itch-inducing cytokine thymic stromal lymphopoietin through amphiregulin-epidermal growth factor receptor signaling. J Allergy Clin Immunol. 2019;144(6):1719-1722.e3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31425777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lessard JC, Piña-Paz S, Rotty JD, et al. . Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci U S A. 2013;110(48):19537-19542. doi:10.1073/pnas.1309576110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1309576110</ArticleId>
            <ArticleId IdType="pmc">PMC3845144</ArticleId>
            <ArticleId IdType="pubmed">24218583</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34468688</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2168-6084</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>157</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA dermatology</Title>
          <ISOAbbreviation>JAMA Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prevalence and Characterization of Itch in Pachyonychia Congenita.</ArticleTitle>
        <Pagination>
          <StartPage>1378</StartPage>
          <EndPage>1380</EndPage>
          <MedlinePgn>1378-1380</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamadermatol.2021.3335</ELocationID>
        <Abstract>
          <AbstractText>This survey study examines the prevalence and characteristics of itch in pachyonychia congenita.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Steele</LastName>
            <ForeName>Lloyd</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, The Royal London Hospital, Barts Health National Health Service Trust and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, England.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schwartz</LastName>
            <ForeName>Janice</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>C David</ForeName>
            <Initials>CD</Initials>
            <AffiliationInfo>
              <Affiliation>Pachyonychia Congenita Project, Holladay, Utah.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University of Utah, Salt Lake City.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Toole</LastName>
            <ForeName>Edel A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, The Royal London Hospital, Barts Health National Health Service Trust and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, England.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JAMA Dermatol</MedlineTA>
        <NlmUniqueID>101589530</NlmUniqueID>
        <ISSNLinking>2168-6068</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="Y">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011537" MajorTopicYN="N">Pruritus</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Conflict of Interest Disclosures:</b> Prof O'Toole reported consulting fees from Palvella Therapeutics, research funding from Kamari Pharma, being a reviewer for LEO Foundation awards and Sanofi, and receiving a Biotechnology and Biological Sciences Research Council cofunded studentship with Unilever outside of the submitted manuscript. No other disclosures were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>12</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34468688</ArticleId>
        <ArticleId IdType="pmc">PMC8411358</ArticleId>
        <ArticleId IdType="doi">10.1001/jamadermatol.2021.3335</ArticleId>
        <ArticleId IdType="pii">2783860</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Samuelov L, Smith FJD, Hansen CD, et al. . Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol. 2020;182(3):738-746. doi:10.1016/j.jid.2019.07.091</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jid.2019.07.091</ArticleId>
            <ArticleId IdType="pubmed">31823354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moons P. Leuven Itch Scale 2.0 Manual. Accessed July 13, 2021. https://gbiomed.kuleuven.be/english/research/50000687/50000693/itchscale</Citation>
        </Reference>
        <Reference>
          <Citation>Pan B, Byrnes K, Schwartz M, et al. . Peripheral neuropathic changes in pachyonychia congenita. Pain. 2016;157(12):2843-2853. doi:10.1097/j.pain.0000000000000711</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000000711</ArticleId>
            <ArticleId IdType="pubmed">27776012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhoff M, Oaklander AL, Szabó IL, Ständer S, Schmelz M. Neuropathic itch. Pain. 2019;160(suppl 1):S11-S16. doi:10.1097/j.pain.0000000000001551</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000001551</ArticleId>
            <ArticleId IdType="pubmed">31008844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson SR, Thé L, Batia LM, et al. . The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285-295. doi:10.1016/j.cell.2013.08.057</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.08.057</ArticleId>
            <ArticleId IdType="pmc">PMC4041105</ArticleId>
            <ArticleId IdType="pubmed">24094650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheffschick A, Kiritsi D, Magin TM. Keratin defects trigger the itch-inducing cytokine thymic stromal lymphopoietin through amphiregulin-epidermal growth factor receptor signaling. J Allergy Clin Immunol. 2019;144(6):1719-1722.e3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31425777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lessard JC, Piña-Paz S, Rotty JD, et al. . Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci U S A. 2013;110(48):19537-19542. doi:10.1073/pnas.1309576110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1309576110</ArticleId>
            <ArticleId IdType="pmc">PMC3845144</ArticleId>
            <ArticleId IdType="pubmed">24218583</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
